| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 3390-61-2 | 1,3,5-三甲基-1,1,3,5,5-五苯基三硅二氧烷 | 1,1,3,5,5-Pentaphenyl-1,3,5-trimethyltrisiloxane; 1,3,5-Trimethyl-1,1,3,5,5-pentaphenyltrisiloxane |  | C33H34O2Si3 | 详情 | 供应商 |
| 123524-52-7 | 阿折地平 | Azelnidipine; 2-Amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-[1-(diphenylmethyl)-3-azetidinyl] 5-(methylethyl) ester |  | C33H34N4O6 | 详情 | 供应商 |
| 134523-03-8 | 阿托伐他汀钙; 7-[2-(4-氟苯基)-3-苯基-4-(苯胺基甲酰基)-5-(2-丙基)吡咯-1-基]-3,5-二羟基庚酸钙 | Atorvastatin calcium; Lipitor; [R-(R*, R*)]-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1H-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt |  | (C33H34FN2O5)2.Ca;C66H68CaF2N4O10 | 详情 | 供应商 |
| 145040-37-5 | 坎地沙坦西来替昔酯; 2-乙氧基-1-[[2'-(1H-四氮唑-5-基)[1,1'-联苯基]-4-基]甲基]-1H-苯并咪唑-7-甲酸-1-[[( | Candesartan cilexetil; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate |  | C33H34N6O6 | 详情 | 供应商 |
| 10028-44-1 | a-D-Glucopyranose,6-O-(triphenylmethyl)-, tetraacetate (9CI); Glucopyranose,6-O-trityl-, tetraacetate, a-D- (8CI); NSC 52915 |  | C33H34O10 | 详情 | 供应商 | |
| 72691-30-6 | a-D-Mannopyranose,6-O-(triphenylmethyl)-, tetraacetate (9CI); 6-O-Trityl-1,2,3,4-tetra-O-acetyl-α-D-mannopyranose |  | C33H34O10 | 详情 | 供应商 | |
| 92621-31-3 | b-D-Mannopyranose,6-O-(triphenylmethyl)-, tetraacetate (9CI); NSC52914 |  | C33H34O10 | 详情 | 供应商 | |
| 28855-11-0 | Trisiloxane,trimethylpentaphenyl-; Dow CorningPH 1555 HRI; SH 705; Trimethylpentaphenyltrisiloxane |  | C33H34O2Si3 | 详情 | 供应商 | |
| 6267-12-5 | 1-Propanone,1-(2,5-diphenyl-3-furanyl)-2,3-di-4-morpholinyl-3-phenyl-; NSC 36711 |  | C33H34N2O4 | 详情 | 供应商 | |
| 153223-23-5 | 2H-1,3-Diazepin-2-one,hexahydro-5,6-dihydroxy-1,3,4,7-tetrakis(phenylmethyl)-, (4R,5S,6S,7R)-; 2H-1,3-Diazepin-2-one,hexahydro-5,6-dihydroxy-1,3,4,7-tetrakis(phenylmethyl)-, [4R-(4a,5a,6b,7b)]- |  | C33H34N2O3 | 详情 | 供应商 | |
| 26359-43-3 | 3-Phorbinepropanoicacid, 3,4-didehydro-9,14-diethyl-4,8,13,18-tetramethyl-20-oxo-; 3-Phorbinepropionicacid, 3,4-didehydro-9,14-diethyl-4,8,13,18-tetramethyl-20-oxo- (8CI); Phylloerythrine (6CI,7CI); Phylloerythrin |  | C33H34N4O3 | 详情 | 供应商 | |
| 111488-20-1 | 9H-Fluorene,2,7-bis(4-methoxyphenyl)-9,9-dipropyl-; E 389; Exalite 389; Oligo 386 |  | C33H34O2 | 详情 | 供应商 | |
| 213843-90-4 | (3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺 | (3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN; (3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE; (3aR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TET&; (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine,min.98%; (3ar,8ar)-(-)-(2,2-dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine; (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98% |  | C33H34NO4P | 详情 | 供应商 |
| 114-25-0 | 去氫膽紅素 | biliverdin; biliverdin; Biliverdine; 3,18-Diethenyl-1,19,22,24-tetrahydro-2,7,13,17-tetrametyl-1,19-dioxo-21H-biline-8,12-dipropanoic Acid; Dehydrobilirubin; Uteroverdine; 3-[2-[(E)-[(5E)-3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-yl)methylidene]-4-methyl-pyrrol-2-ylidene]methyl]-5-[(E)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid; Protobiliverdin IXa; BILIVERDINEDIHYDROCHLORIDE |  | C33H34N4O6 | 详情 | 供应商 |
| 197159-86-7 | 1R,5R,6R-(+)-1,6-双(联苯基膦氧基)螺旋[4.4]壬烷,CTH-(R)-螺P | 1R,5R,6R-(+)-1,6-BIS(DIPHENYLPHOSPHINOXY)SPIRO[4.4]NONANE; CTH-(R)-SPIROP; 1R,5R,6R-(+)-1,6-BIS(DIPHENYLPHOSPHINOXY)SPIRO[4.4]NONANE; min.cth-(r)-spirop; (1R,5R,6R)-(+)-1,6-Bis(diphenylphosphinoxy)spiro[4.4]nonane,min.95%CTH-(R)-SpiroP; 1r,5r,6r-(+)-1,6-bis(diphenylphosphinoxy)spiro[4.4]nonane, cth-(r)-spirop; 1R,5R,6R-(+)-1,6-Bis(diphenylphosphinoxy)spiro[4.4]nonane Application:Asymmetric hydrogenation Store N2; 1R,5R,6R-(+)-1,6-Bis(diphenylphosphinoxy)spiro4.4ünonane, CTH-(R)-SpiroP, 95%; 1R,5R,6 |  | C33H34O2P2 | 详情 | 供应商 |
| 214217-86-4 | ORTHO-HYDROXY ATORVASTATIN; ORTHO-HYDROXY ATORVASTATIN; (R,dR)-2-(4-fluorophenyl)-,d-dihydroxy-4-[[(2-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-pyrrole-1-heptanoic Acid Dihydrate Monosodium Salt; BMS 243887-01; PD 152873; (R,dR)-2-(4-fluorophenyl)-,d-dihydroxy-4-[[(2-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-(phenyl-d5)-1H-pyrrole-1-heptanoic Acid Disodium Salt; o-Hydroxyatorvastatin Disodium Salt; 2-Hydroxy Atorvastatin Dihydrate Monosodium Salt |  | C33H34FN2O6.Na.2H2O | 详情 | 供应商 | |
| 130926-94-2 | MAG-INDO 1-AM; MAG-INDO 1-AM; INDO 1-AM ANALOG; indo 1-am analog selective for*magnesium; MAG-INDO 1-AM, 10X50 UG* | 无 | C33H34N2O17 | 详情 | 供应商 | |
| 124648-92-6 | 6-O-Trityl-1,2,3,4-tetra-O-acetyl-β-D-galactopyranose |  | C33H34O10 | 详情 | 供应商 | |
| 344423-98-9 | 阿托伐他汀钙水合物; 阿托伐他汀钙水合物 | Atorvastatin hemicalcium trihydrate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), trihydrate, (βR,δR)-; atorvastatin calcium hydrate; Atorvastatin hemicalcium trihydrate; Atorvastatin Calcium (100 mg) | 无 | 2(C33H34FN2O5).Ca.3(H2O) | 详情 | 供应商 |
| 95235-29-3 | 6-(异丁基乙基氨)-3-甲基-2-苯氨基-螺(异苯并呋喃-1-(3H),9,-(9H)占吨-3-酮; 6-(异丁基乙基氨)-3-甲基-2-苯? | 6-(Isobutyl ethyl amino)-3-methyl-2-phenylamino-spiro(iso-benzofuran-1-(3H),9,-(9H)xanthene)-3-one; 6-(Isobutyl ethyl amino)-3-methyl-2-phenylamino-spiro(iso-benzofuran-1-(3H),9,-(9H)xanthene)-3-one; 2-Anilino-6-(N-ethyl-N-isobutylamino-3-methyl-fluoran; 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]; 2'-Anilino-6'-(ethylisobutylamino)-3'-methylspiro[phthalide-3,9'-[9H]xanthene]; 3'-(Ethylisobutylamino)-6'-methyl-7'-anilino-spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one; 6'-(Ethylisobutylamino)-2'-anilino-3'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one |  | C33H34N2O3 | 详情 | 供应商 |
sitemap.xml